Literature DB >> 25189529

Whole-genome sequencing of asian lung cancers: second-hand smoke unlikely to be responsible for higher incidence of lung cancer among Asian never-smokers.

Vidhya G Krishnan1, Philip J Ebert2, Jason C Ting2, Elaine Lim3, Swee-Seong Wong2, Audrey S M Teo1, Yong G Yue2, Hui-Hoon Chua1, Xiwen Ma2, Gary S L Loh1, Yuhao Lin2, Joanna H J Tan4, Kun Yu2, Shenli Zhang5, Christoph Reinhard2, Daniel S W Tan6, Brock A Peters7, Stephen E Lincoln7, Dennis G Ballinger7, Jason M Laramie7, Geoffrey B Nilsen7, Thomas D Barber2, Patrick Tan8, Axel M Hillmer4, Pauline C Ng4.   

Abstract

Asian nonsmoking populations have a higher incidence of lung cancer compared with their European counterparts. There is a long-standing hypothesis that the increase of lung cancer in Asian never-smokers is due to environmental factors such as second-hand smoke. We analyzed whole-genome sequencing of 30 Asian lung cancers. Unsupervised clustering of mutational signatures separated the patients into two categories of either all the never-smokers or all the smokers or ex-smokers. In addition, nearly one third of the ex-smokers and smokers classified with the never-smoker-like cluster. The somatic variant profiles of Asian lung cancers were similar to that of European origin with G.C>T.A being predominant in smokers. We found EGFR and TP53 to be the most frequently mutated genes with mutations in 50% and 27% of individuals, respectively. Among the 16 never-smokers, 69% had an EGFR mutation compared with 29% of 14 smokers/ex-smokers. Asian never-smokers had lung cancer signatures distinct from the smoker signature and their mutation profiles were similar to European never-smokers. The profiles of Asian and European smokers are also similar. Taken together, these results suggested that the same mutational mechanisms underlie the etiology for both ethnic groups. Thus, the high incidence of lung cancer in Asian never-smokers seems unlikely to be due to second-hand smoke or other carcinogens that cause oxidative DNA damage, implying that routine EGFR testing is warranted in the Asian population regardless of smoking status. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25189529     DOI: 10.1158/0008-5472.CAN-13-3195

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

Review 1.  Pleural involvement in lung cancer.

Authors:  Theodora Agalioti; Anastasios D Giannou; Georgios T Stathopoulos
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

2.  Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma.

Authors:  Smruthy Sivakumar; F Anthony San Lucas; Tina L McDowell; Wenhua Lang; Li Xu; Junya Fujimoto; Jianjun Zhang; P Andrew Futreal; Junya Fukuoka; Yasushi Yatabe; Steven M Dubinett; Avrum E Spira; Jerry Fowler; Ernest T Hawk; Ignacio I Wistuba; Paul Scheet; Humam Kadara
Journal:  Cancer Res       Date:  2017-09-26       Impact factor: 12.701

3.  DNA Base-Excision Repair Genes OGG1 and NTH1 in Brazilian Lung Cancer Patients.

Authors:  Patricia G Couto; Luciana Bastos-Rodrigues; Juliana G Carneiro; Fernanda Guieiro; Maria Aparecida Bicalho; Franciele B Leidenz; Ana J Bicalho; Eitan Friedman; Luiz De Marco
Journal:  Mol Diagn Ther       Date:  2015-12       Impact factor: 4.074

4.  Trial-Based Cost-Utility Analysis of Icotinib versus Gefitinib as Second-Line Therapy for Advanced Non-Small Cell Lung Cancer in China.

Authors:  Chunxiang Zhang; Hongmei Zhang; Jinning Shi; Dong Wang; Xiuwei Zhang; Jian Yang; Qizhi Zhai; Aixia Ma
Journal:  PLoS One       Date:  2016-03-25       Impact factor: 3.240

Review 5.  Base changes in tumour DNA have the power to reveal the causes and evolution of cancer.

Authors:  M Hollstein; L B Alexandrov; C P Wild; M Ardin; J Zavadil
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

6.  A quantitative method for assessing smoke associated molecular damage in lung cancers.

Authors:  Kai Song; Jia-Hao Bi; Zhe-Wei Qiu; Rui Felizardo; Luc Girard; John D Minna; Adi F Gazdar
Journal:  Transl Lung Cancer Res       Date:  2018-08

7.  Changing paradigm of cancer therapy: precision medicine by next-generation sequencing.

Authors:  Yuan Xue; William R Wilcox
Journal:  Cancer Biol Med       Date:  2016-03       Impact factor: 4.248

8.  Modifiable risk factors of lung cancer in "never-smoker" women.

Authors:  Jong-Myon Bae
Journal:  Epidemiol Health       Date:  2015-10-29

Review 9.  Hormonal Replacement Therapy and the Risk of Lung Cancer in Women: An Adaptive Meta-analysis of Cohort Studies.

Authors:  Jong-Myon Bae; Eun Hee Kim
Journal:  J Prev Med Public Health       Date:  2015-11-09

Review 10.  Human papillomavirus infection and risk of lung cancer in never-smokers and women: an 'adaptive' meta-analysis.

Authors:  Jong-Myon Bae; Eun Hee Kim
Journal:  Epidemiol Health       Date:  2015-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.